Comparing the relative strength of the IFN responses of the top ranked “common” IFN signature probes, it was obvious that the expression levels of the “common” IFN signature genes were relatively stronger in the patients with SLE than in the immunised ND (Table 3). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.